Home Tags DNA
From suicide prevention to genetic testing, there’s a widening disconnect between Silicon Valley health tech and outside experts who see red fla...
"There's almost this implicit assumption that they play by a different set of rules," a Harvard psychiatrist and tech consultant said.
Many of the best at-home DNA kits are on sale right now to celebrate National DNA Day — here’s a quick break down of each one
April 25 is National DNA Day, and many of the best at-home DNA Kits are on sale. Learn about the key differences between the top choices out there.
We’ll be eating the first Crispr’d foods within 5 years, according to a geneticist who helped invent the blockbuster gene-editing tool
A UC Berkeley geneticist who helped invent the gene-editing tool Crispr told Business Insider its most profound impacts will be on agriculture.
Her work was pivotal in discovering DNA's structure, but she never received credit for it during her lifetime.
Scientists have successfully created the world's first gene-edited reptile — an albino lizard no bigger than a finger.
A Silicon Valley startup just launched a DNA-based health test that could be a big competitor to 23andMe
A new genetic test looks at your risk of diseases like cancer and high cholesterol. Unlike 23andMe's test, it includes genetic counseling and full sequencing.
The CEO of Silicon Valley’s favorite meal-replacement startup shares why he thinks the tide is shifting on genetic engineering
"The pendulum is swinging in favor of the science," Soylent CEO Bryan Crowley told Business Insider.
23andMe can now tell you your risk of developing diabetes, based on your DNA. Here’s what doctors want you to know.
The report uses your genetics and other information about you to figure out how likely you are to develop Type 2 diabetes.
Doctors in Australia say they identified semi-identical twins who share all of their mother's DNA but only a portion of their father's DNA.
Swiss drug giant Roche reportedly readies to buy the biotech behind the first FDA-approved gene therapy and the priciest medicine in the US
Roche could pay $5 billion for biotech company Spark Therapeutics. The pharma giant likely wants to expand its presence in hemophilia, a lucrative market.